Free US shipping on orders $250+ · Research Use Only · 14-Day Risk-Free Guarantee
cjc-1295 + ipa
CJC-1295 (No DAC) + Ipamorelin is a dual-peptide blend combining a GHRH analogue with a selective GHRP. Together they stimulate GH release via two separate receptor pathways in preclinical models. Synthesized to >99% purity per component. For in-vitro research use only.
$80.99
14-day risk-free guarantee · Free US shipping on orders $250+
COA / Batch Lookup
Search certificates of analysis by batch number
Get Started →
Dosage
Subscribe & Save
Buy 1
$80.99 each
$80.99
Most Popular
Buy 2 Save 5%
$76.94 each
$153.88
$161.98
Best Value
Buy 3+ Save 10%
$72.89 each
$218.67
$242.97
Subscribe & Save
Discounted per-vial pricing | No hidden fees
1
14-day risk-free guarantee · Secure checkout
Research Use Only — Not for Human Consumption
The CJC-1295 (No DAC) + Ipamorelin combination has been studied for synergistic GH secretagogue activity:
- CJC-1295 (No DAC) binds GHRH receptors, amplifying natural GH pulse amplitude in animal models
- Ipamorelin selectively activates ghrelin receptors without significant cortisol or prolactin elevation in studies
- Dual-pathway stimulation produces greater GH output than either peptide alone in preclinical research
- Supports IGF-1 upregulation in skeletal muscle tissue models
- Short half-life of No DAC formulation allows for more physiological pulsatile GH release patterns
Every batch is independently tested by a US-based third-party laboratory. Our Certificate of Analysis confirms:
Search COA Library →
- Identity of both peptides: confirmed by HPLC and mass spectrometry
- Purity: >99% by HPLC for each component
- Endotoxin: <1 EU/mg
- Appearance: white to off-white lyophilized powder
Search COA Library →
- Teichman SL, et al. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295. J Clin Endocrinol Metab.
- Raun K, et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol.
- Bowers CY. (1998). Growth hormone-releasing peptide (GHRP). Cell Mol Life Sci.
Frequently Paired Compounds
Ipamorelin
GH Secretagogue
MOTS-c
Mitochondrial Peptide
BAC Water
Reconstitution Solution
meet the collection.
Made With
blend
gh-releasing blend · peptide complex
CJC-1295 (No DAC) + Ipamorelin dual-peptide blend — 5 mg each per vial — synthesized to >99% purity per component in a US-based cGMP facility. Each batch independently tested and COA published publicly. Supplied for in-vitro and laboratory research use only.
a gh-releasing blend for growth hormone + performance research.
Purity>99% by HPLC each peptide
FormLyophilized powder
Endotoxin<1 EU/mg
Storage−20°C · 28 days reconstituted
TestingThird-party verified · USA synthesized
FYIResearch Use Only · Not for human use
The CJC-1295 (No DAC) + Ipamorelin combination has been studied for synergistic GH secretagogue activity:
- CJC-1295 (No DAC) binds GHRH receptors, amplifying natural GH pulse amplitude in animal models
- Ipamorelin selectively activates ghrelin receptors without significant cortisol or prolactin elevation in studies
- Dual-pathway stimulation produces greater GH output than either peptide alone in preclinical research
- Supports IGF-1 upregulation in skeletal muscle tissue models
- Short half-life of No DAC formulation allows for more physiological pulsatile GH release patterns
Every batch is independently tested by a US-based third-party laboratory. Our Certificate of Analysis confirms:
Search COA Library →
- Identity of both peptides: confirmed by HPLC and mass spectrometry
- Purity: >99% by HPLC for each component
- Endotoxin: <1 EU/mg
- Appearance: white to off-white lyophilized powder
Search COA Library →
- Teichman SL, et al. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295. J Clin Endocrinol Metab.
- Raun K, et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol.
- Bowers CY. (1998). Growth hormone-releasing peptide (GHRP). Cell Mol Life Sci.
Support
common questions.
Everything you need to know about CJC-1295 + Ipamorelin for your research. Can't find an answer? Contact our team directly.
CJC-1295 (No DAC) is a 29-amino acid analogue of growth hormone-releasing hormone (GHRH) without the Drug Affinity Complex, giving it a shorter, more physiological half-life. Ipamorelin is a pentapeptide GHRP that selectively activates the ghrelin receptor. Together they act on two separate receptor pathways to synergistically stimulate GH pulse secretion in animal models. All activity is from preclinical research only.
The DAC (Drug Affinity Complex) modification extends CJC-1295's half-life significantly by allowing it to bind to serum albumin. The No DAC version (also called Modified GRF 1-29) has a shorter duration of action, more closely mimicking the body's natural pulsatile GH release pattern. Researchers choose No DAC when studying pulsatile GH secretion models.
No. All products sold by Clean Labs USA are strictly for laboratory and in-vitro research use only. They are not drugs, supplements, or food products and are not intended for self-administration or therapeutic use. Purchase constitutes agreement to our Research Use Only terms.
Every order ships with a batch-specific COA. Search our full library at trycleanlabs.com/coa-library. COAs include HPLC purity data, mass spec confirmation, and endotoxin results for both peptide components.
Store lyophilized blend at −20°C in a sealed vial, away from light and moisture. Shelf life exceeds 24 months under these conditions. Once reconstituted, store at 4°C and use within 28 days. Do not freeze reconstituted solution.
shop by category.
Clean Labs USA
the standard for research integrity.
Every compound we carry is synthesized to research-grade standards, third-party verified for purity, and shipped with a full certificate of analysis.
cjc-1295 + ipa